No Picture

As cancer detection companies thrive, Exact Sciences looks to consolidate by spending $2.8B to acquire peer Genomic Health

As predicted by Bloomberg, cancer diagnostics company Exact Sciences is buying peer Genomic Health in a?$2.8 billion cash-and-stock deal.?
Exact Sciences? flagship colorectal cancer test Cologuard will complement Genomic Health?s Oncotype DX, a test de… […]